Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies

Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies

Bibliographic Details
Main Author:	Ala Ali
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Iraqi Journal of Hematology
Online Access:	http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=170;epage=171;aulast=Ali

Similar Items

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Anthracycline-induced cardiotoxicity and senescence
by: Laura K. Booth, et al.
Published: (2022-11-01)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
by: Leila Mabudian, et al.
Published: (2022-09-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
by: Swetha Balaji, et al.
Published: (2023-08-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
by: Yun Qiu, et al.
Published: (2023-12-01)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
by: Aleksandra M. Sobiborowicz-Sadowska, et al.
Published: (2023-01-01)

Detection of anthracycline induced cardiotoxicity by cardiac biomarkers
Published: (2020-11-01)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
by: Marwa Tantawy, et al.
Published: (2021-01-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Assessing cardiotoxicity in randomised trials of anthracycline chemotherapy
by: Kerr, A
Published: (2016)

Genetics of Anthracycline-Associated Cardiotoxicity
by: Talal Khalid Al-Otaibi, et al.
Published: (2022-04-01)

The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
by: Attila Feher, et al.
Published: (2022-04-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
by: Ian Osoro, et al.
Published: (2022-12-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
by: Xi Zhou, et al.
Published: (2023-10-01)

Evaluation of a polymorphism in MYBPC3 in patients with anthracycline induced cardiotoxicity
by: M. Thirumalai Vinodhini, et al.
Published: (2018-03-01)

Transcriptome analysis of long noncoding RNAs reveals their potential roles in anthracycline-induced cardiotoxicity
by: Nhan Nguyen, et al.
Published: (2022-06-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
by: Maryam Moossavi, et al.
Published: (2023-03-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
by: Raquel Araujo-Gutierrez, et al.
Published: (2021-01-01)

Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
by: Anastasia Stella Perpinia, et al.
Published: (2022-08-01)

The Beneficial Role of Physical Exercise on Anthracyclines Induced Cardiotoxicity in Breast Cancer Patients
by: Eliana Tranchita, et al.
Published: (2022-05-01)

About the article “Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients”
by: Elia de la Caridad Rodríguez-Venegas, et al.
Published: (2020-04-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

RADIONUCLIDE METHODS IN THE DETECTION AND FORECAST OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS
by: V. I. Chernov, et al.
Published: (2016-12-01)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
by: Alexandros Briasoulis, et al.
Published: (2022-02-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022-12-01)

Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis
by: Yu Kang, et al.

Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
by: Carmelita Abrahams, et al.
Published: (2022-09-01)